Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study

Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gomez, James Schofield, Joost Brandsma, Andy Shapanis, Paul J. S. Skipp, Anthony Postle, Craig Wheelock, Sven-Erik Dahlen, Peter J. Sterk, Thomas Brown, David J. Jackson, Adel Mansur, Ian Pavord, Mitesh Patel, Christopher Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna Porter, Douglas Robinson, Stephen Fowler, Peter H. Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Alexander Allen, Deborah Ellis, Gareth Griffiths, Tim Harrison, Ayobami Akenroye, Jessica Lasky-Su, Liam Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy

Open source

DOI: 10.1164/rccm.202310-1730oc
Published: 2024-08-01
Container: American Journal of Respiratory and Critical Care Medicine
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1164/rccm.202310-1730oc,
  title = {Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study},
  author = {Ratko Djukanović and Paul Brinkman and Johan Kolmert and Cristina Gomez and James Schofield and Joost Brandsma and Andy Shapanis and Paul J. S. Skipp and Anthony Postle and Craig Wheelock and Sven-Erik Dahlen and Peter J. Sterk and Thomas Brown and David J. Jackson and Adel Mansur and Ian Pavord and Mitesh Patel and Christopher Brightling and Salman Siddiqui and Peter Bradding and Ian Sabroe and Dinesh Saralaya and Livingstone Chishimba and Joanna Porter and Douglas Robinson and Stephen Fowler and Peter H. Howarth and Louisa Little and Thomas Oliver and Kayleigh Hill and Louise Stanton and Alexander Allen and Deborah Ellis and Gareth Griffiths and Tim Harrison and Ayobami Akenroye and Jessica Lasky-Su and Liam Heaney and Rekha Chaudhuri and Ramesh Kurukulaaratchy},
  year = {2024},
  journal = {American Journal of Respiratory and Critical Care Medicine},
  doi = {10.1164/rccm.202310-1730oc},
  url = {https://doi.org/10.1164/rccm.202310-1730oc}
}

RIS

TY  - JOUR
TI  - Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study
AU  - Ratko Djukanović
AU  - Paul Brinkman
AU  - Johan Kolmert
AU  - Cristina Gomez
AU  - James Schofield
AU  - Joost Brandsma
AU  - Andy Shapanis
AU  - Paul J. S. Skipp
AU  - Anthony Postle
AU  - Craig Wheelock
AU  - Sven-Erik Dahlen
AU  - Peter J. Sterk
AU  - Thomas Brown
AU  - David J. Jackson
AU  - Adel Mansur
AU  - Ian Pavord
AU  - Mitesh Patel
AU  - Christopher Brightling
AU  - Salman Siddiqui
AU  - Peter Bradding
AU  - Ian Sabroe
AU  - Dinesh Saralaya
AU  - Livingstone Chishimba
AU  - Joanna Porter
AU  - Douglas Robinson
AU  - Stephen Fowler
AU  - Peter H. Howarth
AU  - Louisa Little
AU  - Thomas Oliver
AU  - Kayleigh Hill
AU  - Louise Stanton
AU  - Alexander Allen
AU  - Deborah Ellis
AU  - Gareth Griffiths
AU  - Tim Harrison
AU  - Ayobami Akenroye
AU  - Jessica Lasky-Su
AU  - Liam Heaney
AU  - Rekha Chaudhuri
AU  - Ramesh Kurukulaaratchy
PY  - 2024
JO  - American Journal of Respiratory and Critical Care Medicine
DO  - 10.1164/rccm.202310-1730oc
UR  - https://doi.org/10.1164/rccm.202310-1730oc
ER  -

APA

Djukanović, R., Brinkman, P., Kolmert, J., Gomez, C., Schofield, J., Brandsma, J., Shapanis, A., Skipp, P. J. S., Postle, A., Wheelock, C., Dahlen, S., Sterk, P. J., Brown, T., Jackson, D. J., Mansur, A., Pavord, I., Patel, M., Brightling, C., Siddiqui, S., Bradding, P., Sabroe, I., Saralaya, D., Chishimba, L., Porter, J., Robinson, D., Fowler, S., Howarth, P. H., Little, L., Oliver, T., Hill, K., Stanton, L., Allen, A., Ellis, D., Griffiths, G., Harrison, T., Akenroye, A., Lasky-Su, J., Heaney, L., Chaudhuri, R., & Kurukulaaratchy, R. (2024). Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.202310-1730oc

Source records

crossref · retrieved 2026-09-26T15:16:01.908Z